Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of nasal chondrocyte-based therapies for knee cartilage lesions
2015-005162-34Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of rimegepant in chondral knee defect (2 arms), sponsored by University Hospital Basel. Primary endpoint: KOOS subjective score at primary timepoint. Started Oct 2016; status: completed.
02
Drugs
rimegepant
03
Conditions
chondral knee defect
Beyond the preview
Go deeper on 2015-005162-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005162-34.